Rafferty Asset Management
PRQR icon

Rafferty Asset Management’s ProQR Therapeutics PRQR Stock Holding History

Rafferty Asset Management’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-21,680
Closed -$46.2K – 1129
2023
Q1 		$46.2K Buy
+21,680
New +$66.3K ﹤0.01% 1134
2022
Q2 		– Sell
-303,356
Closed -$275K – 1206
2022
Q1 		$275K Sell
303,356
-38,727
-11% -$130K ﹤0.01% 1114
2021
Q4 		$2.74M Sell
342,083
-187,800
-35% -$1.43M 0.01% 558
2021
Q3 		$4.43M Sell
529,883
-55,923
-10% -$365K 0.03% 329
2021
Q2 		$3.95M Buy
+585,806
New +$3.78M 0.02% 401

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $480M AUM 77.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $53.8M AUM 28.63% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Rafferty Asset Management's PRQR Position: Q2 2023 in Review

Rafferty Asset Management sold out of ProQR Therapeutics (PRQR) in Q2 2023, closing a stake of 21,680 shares — an estimated $46.2K sold.

Rafferty Asset Management first reported a position in PRQR in Q2 2021 and held it in 5 quarters. The position peaked at $4.43M in Q3 2021. 51 funds tracked by Wall St. Rank hold PRQR as of Q2 2023.

  • Rafferty Asset Management reported no remaining ProQR Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Rafferty Asset Management sold 21,680 ProQR Therapeutics shares in Q2 2023, an estimated $46.2K.
  • Rafferty Asset Management first reported a position in ProQR Therapeutics in Q2 2021 and held it in 5 quarters.
  • Rafferty Asset Management's ProQR Therapeutics position peaked at $4.43M in Q3 2021.
  • 51 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2023.

Based on Rafferty Asset Management's 13F filing for Q2 2023, filed 11 Aug 2023.